109 related articles for article (PubMed ID: 14764781)
1. Transdermal testosterone application: pharmacokinetics and effects on pubertal status, short-term growth, and bone turnover.
Mayo A; Macintyre H; Wallace AM; Ahmed SF
J Clin Endocrinol Metab; 2004 Feb; 89(2):681-7. PubMed ID: 14764781
[TBL] [Abstract][Full Text] [Related]
2. Randomized, crossover comparison study of the short-term effect of oral testosterone undecanoate and intramuscular testosterone depot on linear growth and serum bone alkaline phosphatase.
Ahmed SF; Tucker P; Mayo A; Wallace AM; Hughes IA
J Pediatr Endocrinol Metab; 2004 Jul; 17(7):941-50. PubMed ID: 15301041
[TBL] [Abstract][Full Text] [Related]
3. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone.
Ahmed SF; Tucker P; Mushtaq T; Wallace AM; Williams DM; Hughes IA
Clin Endocrinol (Oxf); 2002 Aug; 57(2):185-91. PubMed ID: 12153596
[TBL] [Abstract][Full Text] [Related]
4. Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth.
Butler GE; Sellar RE; Walker RF; Hendry M; Kelnar CJ; Wu FC
J Clin Endocrinol Metab; 1992 Jul; 75(1):37-44. PubMed ID: 1619029
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
6. Effect of growth hormone dose on bone maturation and puberty in children with idiopathic short stature.
Crowe BJ; Rekers-Mombarg LT; Robling K; Wolka AM; Cutler GB; Wit JM;
J Clin Endocrinol Metab; 2006 Jan; 91(1):169-75. PubMed ID: 16263828
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density and markers of bone turnover in boys with constitutional delay of growth and puberty.
Krupa B; Miazgowski T
J Clin Endocrinol Metab; 2005 May; 90(5):2828-30. PubMed ID: 15687323
[TBL] [Abstract][Full Text] [Related]
8. Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
Pediatr Res; 2000 Oct; 48(4):490-6. PubMed ID: 11004240
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of testosterone.
Hadgraft J; Lane ME
Eur J Pharm Biopharm; 2015 May; 92():42-8. PubMed ID: 25709060
[TBL] [Abstract][Full Text] [Related]
10. [Serum osteocalcin and bone alkaline phosphatase in healthy children in relation to age and gender].
Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
Med Wieku Rozwoj; 2002; 6(3):257-65. PubMed ID: 12637780
[TBL] [Abstract][Full Text] [Related]
11. Testosterone administration in women with anorexia nervosa.
Miller KK; Grieco KA; Klibanski A
J Clin Endocrinol Metab; 2005 Mar; 90(3):1428-33. PubMed ID: 15613421
[TBL] [Abstract][Full Text] [Related]
12. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
Wickman S; Kajantie E; Dunkel L
J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
[TBL] [Abstract][Full Text] [Related]
13. The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer.
Taxel P; Fall PM; Albertsen PC; Dowsett RD; Trahiotis M; Zimmerman J; Ohannessian C; Raisz LG
J Clin Endocrinol Metab; 2002 Nov; 87(11):4907-13. PubMed ID: 12414849
[TBL] [Abstract][Full Text] [Related]
14. Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
Uebelhart B; Herrmann F; Pavo I; Draper MW; Rizzoli R
J Bone Miner Res; 2004 Sep; 19(9):1518-24. PubMed ID: 15312253
[TBL] [Abstract][Full Text] [Related]
15. Bone Turnover and Growth during and after Chemotherapy in Children with Solid Tumors.
Bath LF; Crofton PM; Evans AE; Ranke MB; Elmlinger MW; Kelnar CJ; Wallace WH
Pediatr Res; 2004 Feb; 55(2):224-30. PubMed ID: 14605245
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of androgens and estrogens on bone turnover in normal men.
Leder BZ; LeBlanc KM; Schoenfeld DA; Eastell R; Finkelstein JS
J Clin Endocrinol Metab; 2003 Jan; 88(1):204-10. PubMed ID: 12519853
[TBL] [Abstract][Full Text] [Related]
18. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. Estrogen levels as determined by an ultrasensitive bioassay.
Klein KO; Martha PM; Blizzard RM; Herbst T; Rogol AD
J Clin Endocrinol Metab; 1996 Sep; 81(9):3203-7. PubMed ID: 8784070
[TBL] [Abstract][Full Text] [Related]
20. [Some bone turnover markers in serum of healthy children and adolescents in relation to age and gender].
Gajewska J; Ambroszkiewicz J; Laskowska-Klita T
Wiad Lek; 2005; 58(9-10):476-80. PubMed ID: 16529055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
